Last 48 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.08 | — | — | 0.20 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.20 | — | — | 3.41 | 2.05 | 2.66 | 1.87 | 1.75 | 2.73 | 3.94 | 7.53 | 6.82 | 3.33 | 9.13 | 6.27 | 4.59 | 5.81 | 9.43 | 26.51 | 34.78 | 59.00 |
| — | — | — | +94.6% | -25.0% | -32.4% | -75.1% | -74.3% | -17.9% | -56.8% | +20.2% | +48.6% | -42.7% | -3.1% | -76.4% | -86.8% | -90.2% | -88.3% | -77.6% | -22.6% | +913.9% | |
| P/B Ratio | 0.11 | 4.75 | 0.83 | 2.85 | — | — | — | — | — | — | 6.64 | 3.74 | 1.27 | 3.06 | 1.57 | 1.14 | 1.18 | 1.45 | 2.87 | 4.81 | 6.97 |
| — | — | — | — | — | — | — | — | — | — | +322.2% | +228.4% | +8.2% | +110.4% | -45.2% | -76.3% | -83.1% | -77.9% | -66.2% | +15.6% | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | 0.15 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 99.5% | — | — | 100.0% | 99.5% | 99.4% | 99.4% | 99.5% | 99.2% | 99.5% | 97.7% | 98.0% | 97.9% | 96.6% | 99.0% | 97.5% | 97.8% | 98.2% | 96.0% | 95.0% | 95.0% |
| — | — | — | +0.5% | +0.3% | -0.1% | +1.7% | +1.5% | +1.4% | +3.0% | -1.2% | +0.5% | +0.1% | -1.6% | +3.1% | +2.7% | +2.9% | +3.5% | +1.0% | -0.0% | -0.0% | |
| Operating Margin | -348.4% | — | — | -665.2% | -218.0% | -300.1% | -426.8% | -268.9% | -360.5% | -491.4% | -597.7% | -452.5% | -436.6% | -552.5% | -506.2% | -354.0% | -446.2% | -629.4% | -735.7% | -400.9% | -330.6% |
| — | — | — | -147.4% | +39.5% | +38.9% | +28.6% | +40.6% | +17.4% | +11.0% | -18.1% | -27.8% | +2.2% | +12.2% | +31.2% | +11.7% | -35.0% | -35.1% | -83.0% | -93.2% | -92.4% | |
| Net Margin | -80.3% | — | — | 1700.9% | -243.4% | -312.6% | -446.1% | -287.5% | -344.3% | -463.6% | -569.3% | -434.4% | -430.0% | -544.4% | -503.2% | -392.4% | -470.6% | -666.1% | -783.1% | -434.4% | -363.6% |
| — | — | — | +691.5% | +29.3% | +32.6% | +21.7% | +33.8% | +19.9% | +14.8% | -13.1% | -10.7% | +8.6% | +18.3% | +35.7% | +9.7% | -29.4% | -40.5% | -72.7% | -74.8% | -66.9% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -138.8% | -98.6% | -266.4% | 354.4% | — | — | — | — | — | -269.2% | -81.5% | -47.6% | -43.6% | -38.1% | -27.8% | -22.1% | -22.6% | -23.1% | -19.3% | -14.1% | -10.3% |
| — | — | — | — | — | — | — | — | — | -606.9% | -193.2% | -114.7% | -93.4% | -64.9% | -43.9% | -57.4% | -120.0% | -149.8% | -145.9% | +4.5% | — | |
| ROA | -24.8% | -35.3% | -97.5% | 81.3% | -27.2% | -25.1% | -26.3% | -23.0% | -21.7% | -21.0% | -17.1% | -14.0% | -14.0% | -13.4% | -11.4% | -9.8% | -10.6% | -11.8% | -10.6% | -8.1% | -6.3% |
| — | -40.7% | -270.0% | +454.0% | -25.1% | -19.4% | -54.5% | -64.0% | -55.5% | -57.0% | -50.0% | -43.2% | -32.3% | -13.1% | -6.9% | -20.0% | -68.9% | -102.8% | -111.5% | -35.5% | +52.5% | |
| ROIC | — | — | -1627.0% | — | — | — | — | — | — | -125.3% | -104.5% | -457.6% | -103.1% | -99.2% | -44.3% | -25.2% | -30.2% | -24.1% | -19.4% | -17.0% | -15.4% |
| — | — | — | — | — | — | — | — | — | -26.3% | -136.1% | -1718.7% | -241.1% | -311.7% | -128.2% | -47.9% | -96.2% | +9.4% | +61.8% | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.30 | 0.22 | 0.11 | 0.30 | — | — | — | — | — | — | 4.50 | 0.14 | 0.10 | 0.13 | 0.10 | 0.08 | 0.08 | 0.07 | 0.05 | 0.06 | 0.05 |
| — | — | — | — | — | — | — | — | — | — | +4385.9% | +67.8% | +38.7% | +79.7% | +102.6% | +52.4% | +49.3% | +51.1% | -5.3% | -5.2% | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.49 | 0.49 | 1.00 | 0.49 | 0.70 | 0.74 | 1.23 | 1.39 | 1.22 | 1.78 | 4.08 | 2.77 | 5.36 | 7.01 | 9.67 | 9.20 | 7.69 | 9.33 | 13.02 | 9.11 | 14.25 |
| — | -33.9% | -18.8% | -64.6% | -42.9% | -58.2% | -69.7% | -49.9% | -77.2% | -74.6% | -57.8% | -69.9% | -30.4% | -24.9% | -25.7% | +1.0% | -46.0% | -53.1% | -43.8% | -46.9% | +359.2% | |
| Quick Ratio | 0.49 | 0.49 | 1.00 | 0.49 | 0.70 | 0.74 | 1.23 | 1.39 | 1.22 | 1.78 | 4.08 | 2.77 | 5.36 | 7.01 | 9.67 | 9.20 | 7.69 | 9.33 | 13.02 | 9.11 | 14.25 |
| — | -33.9% | -18.8% | -64.6% | -42.9% | -58.2% | -69.7% | -49.9% | -77.2% | -74.6% | -57.8% | -69.9% | -30.4% | -24.9% | -25.7% | +1.0% | -46.0% | -53.1% | -43.8% | -46.9% | +359.2% | |
| Interest Coverage | -2.47 | — | — | — | — | — | — | -11.75 | — | — | — | -4.59 | — | -17.75 | — | -5.86 | -12.00 | -14.31 | -14.25 | -11.31 | -9.46 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying CRIS stock.
Curis, Inc.'s current P/E is -0.1x. The average P/E over the last 1 quarters is 0.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Curis, Inc.'s current operating margin is -348.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Curis, Inc.'s business trajectory between earnings reports.